Romidepsin and Bionor's HIV vaccine Vacc-4x achieves primary endpoint in phase I/II trial Dec. 24, 2015
Texas Biomedical Research Institute receives NIH grant to develop cure for HIV infection in infants Dec. 7, 2015
Maximal virologic suppression reported at 1 year in phase IIb extension study of PRO-140 Dec. 2, 2015
RSS